Er-Kim and Sentynl Therapeutics Partner to Expand Access to Rare Disease Treatments in EMEA and Eurasian Markets Read more
Biostar Pharma’s Utidelone Receives Third Orphan Drug Designation from FDA for Pancreatic Cancer Read more
Cellectar Biosciences Partners with Evestia Clinical for Phase 1b Trial of CLR 125 in Triple-Negative Breast Cancer Read more
FDA Grants Priority Review to AstraZeneca and Daiichi Sankyo’s Enhertu for First-Line HER2-Positive Metastatic Breast Cancer Read more